29 related articles for article (PubMed ID: 7944004)
1. A biofabricated vascularized skin model of atopic dermatitis for preclinical studies.
Liu X; Michael S; Bharti K; Ferrer M; Song MJ
Biofabrication; 2020 Apr; 12(3):035002. PubMed ID: 32059197
[TBL] [Abstract][Full Text] [Related]
2. VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.
Chen L; Lin SX; Amin S; Overbergh L; Maggiolino G; Chan LS
Immunol Cell Biol; 2010; 88(3):334-42. PubMed ID: 20065994
[TBL] [Abstract][Full Text] [Related]
3. Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis.
El-Mezzein RE; Matsumoto T; Nomiyama H; Miike T
Clin Exp Immunol; 2001 Nov; 126(2):193-8. PubMed ID: 11703360
[TBL] [Abstract][Full Text] [Related]
4. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis.
Oh JW; Shin JC; Jang SJ; Lee HB
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):579-85. PubMed ID: 10400487
[TBL] [Abstract][Full Text] [Related]
5. [Peripheral eosinophil counts relates the improvement of the skin lesions of atopic dermatitis patients more sensitive than serum eosinophil cationic protein levels].
Nishimoto M; Numahara T; Nakashima K; Yoshida T
Arerugi; 1998 Jun; 47(6):591-6. PubMed ID: 9721450
[TBL] [Abstract][Full Text] [Related]
6. Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy.
Huang JL; Lee WY; Chen LC; Kuo ML; Hsieh KH
Ann Allergy Asthma Immunol; 2000 Mar; 84(3):345-52. PubMed ID: 10752921
[TBL] [Abstract][Full Text] [Related]
7. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
[TBL] [Abstract][Full Text] [Related]
8. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
[TBL] [Abstract][Full Text] [Related]
9. Circulating ICAM-1 levels in children with atopic dermatitis.
Kojima T; Ono A; Aoki T; Kameda-Hayashi N; Kobayashi Y
Ann Allergy; 1994 Oct; 73(4):351-5. PubMed ID: 7944004
[TBL] [Abstract][Full Text] [Related]
10. [The role of eosinophilic granulocytes for the pathogenesis of atopic dermatitis /neurodermatitis. Eosinophilic products as markers of disease activity].
Kapp A
Hautarzt; 1993 Jul; 44(7):432-6. PubMed ID: 8365876
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil chemiluminescence response to cytokines and opsonized zymosans in atopic dermatitis.
Miyasato M; Taguchi K; Tsuda S; Kitamura N; Kato K
Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):24-6. PubMed ID: 8155999
[TBL] [Abstract][Full Text] [Related]
12. [Tissue eosinophilia and local deposition of eosinophil-specific granule proteins. Regulation and significance for inflammatory response in atopic dermatitis and other inflammatory dermatoses].
Kiehl P; Kapp A
Hautarzt; 1998 Mar; 49(3):176-83. PubMed ID: 9565784
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
